Strides’ extensive experience in supplying specialty products to regulated markets worldwide has provided the opportunity to focus on the emerging, unmet need for quality critical care in India and paved the way for the launch of Ray of Life. Ray of Life leverages Stride’s specialty portfolio to offer a range of oncology, nephrology and hi-end antibiotics for the Indian market. The products are manufactured at Strides’ fully automated facilities approved by the world’s most regulated market authorities.

The range of high quality products include the most sought after and newest molecules that offer the highest degree of patient care like penems and injectables for the treatment of MRSA and gram positive infections. The adherence to quality, however, does not rest at making superior products. It is ingrained in every aspect of Ray of Life’s business. Our cytotoxic oncology products, for instance, are packaged in special Oncotainers which prevent any adverse effects or contamination in the event of breakage or spillage, ensuring that the product reaches the customer safely and to the same quality standards to which it was manufactured. We have in place a best in class sales team with extensive experience in their respective verticals to meet the needs of the highly specialised individual and institutional segments we serve.